Cargando…

What influences uptake and early adherence to Option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in Central Uganda? A mixed methods study

BACKGROUND: High uptake and optimal adherence to Option B+ antiretroviral therapy (ART) increase effectiveness in averting mother-to-child transmission of HIV. Option B+ ART uptake, early adherence, and associated factors need to be evaluated in Central Uganda. METHODS: A mixed approaches study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukose, Aggrey David, Bastiaens, Hilde, Makumbi, Fredrick, Buregyeya, Esther, Naigino, Rose, Musinguzi, Joshua, Van Geertruyden, Jean-Pierre, Wanyenze, Rhoda K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099116/
https://www.ncbi.nlm.nih.gov/pubmed/33951109
http://dx.doi.org/10.1371/journal.pone.0251181
_version_ 1783688538697498624
author Mukose, Aggrey David
Bastiaens, Hilde
Makumbi, Fredrick
Buregyeya, Esther
Naigino, Rose
Musinguzi, Joshua
Van Geertruyden, Jean-Pierre
Wanyenze, Rhoda K.
author_facet Mukose, Aggrey David
Bastiaens, Hilde
Makumbi, Fredrick
Buregyeya, Esther
Naigino, Rose
Musinguzi, Joshua
Van Geertruyden, Jean-Pierre
Wanyenze, Rhoda K.
author_sort Mukose, Aggrey David
collection PubMed
description BACKGROUND: High uptake and optimal adherence to Option B+ antiretroviral therapy (ART) increase effectiveness in averting mother-to-child transmission of HIV. Option B+ ART uptake, early adherence, and associated factors need to be evaluated in Central Uganda. METHODS: A mixed approaches study was carried out in six health facilities in Masaka, Mityana, and Luwero districts from October 2013 to February 2016. Questionnaires were administered to 507 HIV positive pregnant females seeking antenatal care services. Key informant interviews were conducted with 54 health providers, and in-depth interviews (IDIs) with 57 HIV positive women on Option B+ ART. Quantitative data were analyzed using log-binomial regression model to determine factors associated with optimal adherence (taking at least 95% of the prescribed ART), while thematic analysis was used on qualitative data. RESULTS: Ninety one percent of women (463/507) received a prescription of life long ART. Of these, 93.3% (432/463) started swallowing their medicines. Overall, 83% of women who received ART prescriptions (310/374) felt they were ready to initiate ART immediately. Main motivating factors to swallow ART among those who received a prescription were women’s personal desire to be healthy (92.3%) and desire to protect their babies (90.6%). Optimal adherence to ART was achieved by 76.8% (315/410). Adherence was higher among females who were ready to start ART (adj. PR = 3.20; 95% CI: 1.15–8.79) and those who had revealed their HIV positive result to someone (adj. PR = 1.23; 95% CI: 1.04–1.46). Facilitators of ART uptake from qualitative findings included adequate counseling, willingness to start, and knowing the benefits of ART. Reasons for refusal to start ART included being unready to start ART, fear to take ART for life, doubt of HIV positive results, and preference for local herbs. Reasons for non-adherence were travelling far away from health facilities, fear of side effects, non-disclosure of HIV results to anyone, and perception that the baby is safe from HIV infection post-delivery. CONCLUSIONS: Uptake of Option B+ ART was very high. However, failure to start swallowing ART and sub-optimal adherence are a major public health concern. Enhancing women’s readiness to start ART and encouraging HIV result revelation could improve ART uptake and adherence.
format Online
Article
Text
id pubmed-8099116
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-80991162021-05-17 What influences uptake and early adherence to Option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in Central Uganda? A mixed methods study Mukose, Aggrey David Bastiaens, Hilde Makumbi, Fredrick Buregyeya, Esther Naigino, Rose Musinguzi, Joshua Van Geertruyden, Jean-Pierre Wanyenze, Rhoda K. PLoS One Research Article BACKGROUND: High uptake and optimal adherence to Option B+ antiretroviral therapy (ART) increase effectiveness in averting mother-to-child transmission of HIV. Option B+ ART uptake, early adherence, and associated factors need to be evaluated in Central Uganda. METHODS: A mixed approaches study was carried out in six health facilities in Masaka, Mityana, and Luwero districts from October 2013 to February 2016. Questionnaires were administered to 507 HIV positive pregnant females seeking antenatal care services. Key informant interviews were conducted with 54 health providers, and in-depth interviews (IDIs) with 57 HIV positive women on Option B+ ART. Quantitative data were analyzed using log-binomial regression model to determine factors associated with optimal adherence (taking at least 95% of the prescribed ART), while thematic analysis was used on qualitative data. RESULTS: Ninety one percent of women (463/507) received a prescription of life long ART. Of these, 93.3% (432/463) started swallowing their medicines. Overall, 83% of women who received ART prescriptions (310/374) felt they were ready to initiate ART immediately. Main motivating factors to swallow ART among those who received a prescription were women’s personal desire to be healthy (92.3%) and desire to protect their babies (90.6%). Optimal adherence to ART was achieved by 76.8% (315/410). Adherence was higher among females who were ready to start ART (adj. PR = 3.20; 95% CI: 1.15–8.79) and those who had revealed their HIV positive result to someone (adj. PR = 1.23; 95% CI: 1.04–1.46). Facilitators of ART uptake from qualitative findings included adequate counseling, willingness to start, and knowing the benefits of ART. Reasons for refusal to start ART included being unready to start ART, fear to take ART for life, doubt of HIV positive results, and preference for local herbs. Reasons for non-adherence were travelling far away from health facilities, fear of side effects, non-disclosure of HIV results to anyone, and perception that the baby is safe from HIV infection post-delivery. CONCLUSIONS: Uptake of Option B+ ART was very high. However, failure to start swallowing ART and sub-optimal adherence are a major public health concern. Enhancing women’s readiness to start ART and encouraging HIV result revelation could improve ART uptake and adherence. Public Library of Science 2021-05-05 /pmc/articles/PMC8099116/ /pubmed/33951109 http://dx.doi.org/10.1371/journal.pone.0251181 Text en © 2021 Mukose et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Mukose, Aggrey David
Bastiaens, Hilde
Makumbi, Fredrick
Buregyeya, Esther
Naigino, Rose
Musinguzi, Joshua
Van Geertruyden, Jean-Pierre
Wanyenze, Rhoda K.
What influences uptake and early adherence to Option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in Central Uganda? A mixed methods study
title What influences uptake and early adherence to Option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in Central Uganda? A mixed methods study
title_full What influences uptake and early adherence to Option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in Central Uganda? A mixed methods study
title_fullStr What influences uptake and early adherence to Option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in Central Uganda? A mixed methods study
title_full_unstemmed What influences uptake and early adherence to Option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in Central Uganda? A mixed methods study
title_short What influences uptake and early adherence to Option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in Central Uganda? A mixed methods study
title_sort what influences uptake and early adherence to option b+ (lifelong antiretroviral therapy among hiv positive pregnant and breastfeeding women) in central uganda? a mixed methods study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099116/
https://www.ncbi.nlm.nih.gov/pubmed/33951109
http://dx.doi.org/10.1371/journal.pone.0251181
work_keys_str_mv AT mukoseaggreydavid whatinfluencesuptakeandearlyadherencetooptionblifelongantiretroviraltherapyamonghivpositivepregnantandbreastfeedingwomenincentralugandaamixedmethodsstudy
AT bastiaenshilde whatinfluencesuptakeandearlyadherencetooptionblifelongantiretroviraltherapyamonghivpositivepregnantandbreastfeedingwomenincentralugandaamixedmethodsstudy
AT makumbifredrick whatinfluencesuptakeandearlyadherencetooptionblifelongantiretroviraltherapyamonghivpositivepregnantandbreastfeedingwomenincentralugandaamixedmethodsstudy
AT buregyeyaesther whatinfluencesuptakeandearlyadherencetooptionblifelongantiretroviraltherapyamonghivpositivepregnantandbreastfeedingwomenincentralugandaamixedmethodsstudy
AT naiginorose whatinfluencesuptakeandearlyadherencetooptionblifelongantiretroviraltherapyamonghivpositivepregnantandbreastfeedingwomenincentralugandaamixedmethodsstudy
AT musinguzijoshua whatinfluencesuptakeandearlyadherencetooptionblifelongantiretroviraltherapyamonghivpositivepregnantandbreastfeedingwomenincentralugandaamixedmethodsstudy
AT vangeertruydenjeanpierre whatinfluencesuptakeandearlyadherencetooptionblifelongantiretroviraltherapyamonghivpositivepregnantandbreastfeedingwomenincentralugandaamixedmethodsstudy
AT wanyenzerhodak whatinfluencesuptakeandearlyadherencetooptionblifelongantiretroviraltherapyamonghivpositivepregnantandbreastfeedingwomenincentralugandaamixedmethodsstudy